Meta Biomed Past Earnings Performance
Past criteria checks 5/6
Meta Biomed has been growing earnings at an average annual rate of 35.5%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 10.1% per year. Meta Biomed's return on equity is 13.8%, and it has net margins of 12.4%.
Key information
35.5%
Earnings growth rate
35.7%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 10.1% |
| Return on equity | 13.8% |
| Net Margin | 12.4% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Earnings Tell The Story For Meta Biomed Co., Ltd. (KOSDAQ:059210) As Its Stock Soars 30%
Feb 26
Here's How We Evaluate Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Dividend
Apr 11Meta Biomed's (KOSDAQ:059210) Stock Price Has Reduced 58% In The Past Five Years
Mar 14Are Meta Biomed's (KOSDAQ:059210) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 21Can Meta Biomed (KOSDAQ:059210) Continue To Grow Its Returns On Capital?
Feb 03
Is Meta Biomed (KOSDAQ:059210) A Risky Investment?
Jan 13Here's Why I Think Meta Biomed (KOSDAQ:059210) Is An Interesting Stock
Dec 26Meta Biomed (KOSDAQ:059210) Share Prices Have Dropped 22% In The Last Five Years
Dec 08Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 20Revenue & Expenses BreakdownBeta
How Meta Biomed makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 83,101 | 10,292 | 21,638 | 4,538 |
| 30 Sep 23 | 79,545 | 7,360 | 20,066 | 4,353 |
| 30 Jun 23 | 77,747 | 3,715 | 20,057 | 4,374 |
| 31 Mar 23 | 75,428 | 5,399 | 19,720 | 4,711 |
| 31 Dec 22 | 68,942 | 1,874 | 18,510 | 4,343 |
| 30 Sep 22 | 66,883 | 7,127 | 18,337 | 4,491 |
| 30 Jun 22 | 61,372 | 8,604 | 17,282 | 4,219 |
| 31 Mar 22 | 60,795 | 8,832 | 15,592 | 3,624 |
| 31 Dec 21 | 58,780 | 9,381 | 15,371 | 3,339 |
| 30 Sep 21 | 54,183 | 4,490 | 12,632 | 3,048 |
| 30 Jun 21 | 51,861 | 4,196 | 12,017 | 2,724 |
| 31 Mar 21 | 45,793 | -1,093 | 12,525 | 2,298 |
| 31 Dec 20 | 44,998 | -3,091 | 13,518 | 2,227 |
| 30 Sep 20 | 46,823 | 2,035 | 14,180 | 2,070 |
| 30 Jun 20 | 49,075 | 1,980 | 15,637 | 2,032 |
| 31 Mar 20 | 56,034 | 5,445 | 16,617 | 2,405 |
| 31 Dec 19 | 59,391 | 5,527 | 16,403 | 2,453 |
| 30 Sep 19 | 52,268 | 156 | 17,199 | 2,395 |
| 30 Jun 19 | 53,192 | 64 | 18,590 | 2,433 |
| 31 Mar 19 | 51,518 | -1,435 | 17,538 | 2,221 |
| 31 Dec 18 | 52,586 | 953 | 17,958 | 2,013 |
| 30 Sep 18 | 64,158 | -4,131 | 16,742 | 2,425 |
| 30 Jun 18 | 65,530 | -2,666 | 15,170 | 2,257 |
| 31 Mar 18 | 66,563 | -2,753 | 16,473 | 2,167 |
| 31 Dec 17 | 65,341 | -4,104 | 15,970 | 2,157 |
| 30 Sep 17 | 66,531 | 262 | 18,570 | 2,289 |
| 30 Jun 17 | 64,329 | -635 | 16,486 | 2,348 |
| 31 Mar 17 | 64,383 | 761 | 16,338 | 2,333 |
| 31 Dec 16 | 65,784 | 639 | 16,393 | 2,382 |
| 30 Sep 16 | 65,639 | 2,240 | 16,317 | 1,422 |
| 30 Jun 16 | 67,236 | 1,476 | 17,789 | 1,486 |
| 31 Mar 16 | 68,227 | 322 | 17,524 | 1,497 |
| 31 Dec 15 | 68,592 | 806 | 16,768 | 1,394 |
| 30 Sep 15 | 67,332 | -2,369 | 16,906 | 1,886 |
| 30 Jun 15 | 66,230 | -3,088 | 15,172 | 1,721 |
| 31 Mar 15 | 63,748 | -4,242 | 14,417 | 2,161 |
| 31 Dec 14 | 61,365 | -4,952 | 14,102 | 2,071 |
| 30 Sep 14 | 58,403 | -1,117 | 12,684 | 2,047 |
| 30 Jun 14 | 59,885 | -619 | 13,139 | 2,303 |
| 31 Mar 14 | 63,423 | 1,752 | 12,158 | 1,777 |
| 31 Dec 13 | 63,518 | 1,967 | 11,652 | 1,777 |
| 30 Sep 13 | 65,701 | 2,844 | 10,746 | 967 |
| 30 Jun 13 | 62,564 | 3,418 | 10,352 | 589 |
Quality Earnings: A059210 has high quality earnings.
Growing Profit Margin: A059210's current net profit margins (12.4%) are higher than last year (2.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A059210's earnings have grown significantly by 35.5% per year over the past 5 years.
Accelerating Growth: A059210's earnings growth over the past year (449.3%) exceeds its 5-year average (35.5% per year).
Earnings vs Industry: A059210 earnings growth over the past year (449.3%) exceeded the Medical Equipment industry 8.8%.
Return on Equity
High ROE: A059210's Return on Equity (13.8%) is considered low.